Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279728

Director acquired 29,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lucidi Bruno Director 2026-06-18 Option exercise +29,600 142,350 D
Derivatives
Lucidi Bruno Director 2026-06-18 Option exercise · Restricted Stock Units −29,600 0 D
Lucidi Bruno Director 2026-06-18 Grant or award · Restricted Stock Units +26,700 26,700 D
Lucidi Bruno Director 2026-06-18 Grant or award · Stock Option (Right to Buy) +37,700 37,700 D
Loading xslF345X06/ownership.xml…